1. Home
  2. STTK vs FCCO Comparison

STTK vs FCCO Comparison

Compare STTK & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STTK
  • FCCO
  • Stock Information
  • Founded
  • STTK 2016
  • FCCO 1994
  • Country
  • STTK United States
  • FCCO United States
  • Employees
  • STTK N/A
  • FCCO N/A
  • Industry
  • STTK Biotechnology: Pharmaceutical Preparations
  • FCCO Major Banks
  • Sector
  • STTK Health Care
  • FCCO Finance
  • Exchange
  • STTK Nasdaq
  • FCCO Nasdaq
  • Market Cap
  • STTK 173.6M
  • FCCO 166.4M
  • IPO Year
  • STTK 2020
  • FCCO 1998
  • Fundamental
  • Price
  • STTK $3.74
  • FCCO $22.70
  • Analyst Decision
  • STTK Strong Buy
  • FCCO Buy
  • Analyst Count
  • STTK 3
  • FCCO 1
  • Target Price
  • STTK $10.67
  • FCCO $21.00
  • AVG Volume (30 Days)
  • STTK 129.3K
  • FCCO 18.4K
  • Earning Date
  • STTK 11-07-2024
  • FCCO 10-16-2024
  • Dividend Yield
  • STTK N/A
  • FCCO 2.66%
  • EPS Growth
  • STTK N/A
  • FCCO N/A
  • EPS
  • STTK N/A
  • FCCO 1.42
  • Revenue
  • STTK $4,123,999.00
  • FCCO $59,227,000.00
  • Revenue This Year
  • STTK $164.45
  • FCCO N/A
  • Revenue Next Year
  • STTK N/A
  • FCCO $9.86
  • P/E Ratio
  • STTK N/A
  • FCCO $15.98
  • Revenue Growth
  • STTK 380.09
  • FCCO N/A
  • 52 Week Low
  • STTK $1.33
  • FCCO $15.40
  • 52 Week High
  • STTK $11.76
  • FCCO $23.30
  • Technical
  • Relative Strength Index (RSI)
  • STTK 52.85
  • FCCO 64.87
  • Support Level
  • STTK $3.60
  • FCCO $21.28
  • Resistance Level
  • STTK $3.82
  • FCCO $22.79
  • Average True Range (ATR)
  • STTK 0.23
  • FCCO 0.56
  • MACD
  • STTK 0.03
  • FCCO 0.07
  • Stochastic Oscillator
  • STTK 64.91
  • FCCO 96.07

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

About FCCO First Community Corporation

First Community Corp is a bank holding company, which provides commercial banking services. It is engaged in the general commercial and retail banking business characterized by personalized service and local decision making, emphasizing the banking needs of small to medium-sized businesses, professional concerns, and individuals. It operates through following segments: Commercial and Retail Banking; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate. It offers checking, savings, money market, individual retirement, and certificates of deposit accounts. Its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others.

Share on Social Networks: